Cargando…
Targeting Mitochondria as Therapeutic Strategy for Metabolic Disorders
Mitochondria are critical regulator of cell metabolism; thus, mitochondrial dysfunction is associated with many metabolic disorders. Defects in oxidative phosphorylation, ROS production, or mtDNA mutations are the main causes of mitochondrial dysfunction in many pathological conditions such as IR/di...
Autores principales: | Sorriento, Daniela, Pascale, Antonietta Valeria, Finelli, Rosa, Carillo, Anna Lisa, Annunziata, Roberto, Trimarco, Bruno, Iaccarino, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976884/ https://www.ncbi.nlm.nih.gov/pubmed/24757426 http://dx.doi.org/10.1155/2014/604685 |
Ejemplares similares
-
Adrenergic Mechanism in the Control of Endothelial Function
por: Sorriento, Daniela, et al.
Publicado: (2011) -
Cardiac Nonmyocyte Cell Functions and Crosstalks in Response to Cardiotoxic Drugs
por: Gambardella, Jessica, et al.
Publicado: (2017) -
Trafficking GRK2: Cellular and Metabolic consequences of GRK2 subcellular localization.
por: Sorriento, Daniela, et al.
Publicado: (2014) -
The Antioxidant Therapy: New Insights in the Treatment of Hypertension
por: Sorriento, Daniela, et al.
Publicado: (2018) -
“Freeze, Don’t Move”: How to Arrest a Suspect in Heart Failure – A Review on Available GRK2 Inhibitors
por: Sorriento, Daniela, et al.
Publicado: (2016)